# Standard Chartered Rises, Stellantis Gains, GSK Falls

An episode of [Stock Movers](https://invisiblenetwork.ai/podcast/1803209456), 28 Oct 2026, 4:17.

Audio: https://podtrac.com/pts/redirect.mp3/traffic.omny.fm/d/clips/e73c998e-6e60-432f-8610-ae210140c5b1/deb345cd-6d73-4a24-a6e3-b2a50138dd86/c7ca4573-1414-4723-ae4a-b4f10095aa33/audio.mp3?utm_source=Podcast&in_playlist=a55c6f22-aa32-4a58-aebd-b2a50138e2b2

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Standard Chartered shares gain as much as 5.2% in London, the most in three months, after the Asia-focused lender delivered third-quarter results ahead of expectations and raised its full-year guidance. Analysts highlight broad-based strength across the banking group, with consensus earnings estimates expected to rise by low to mid-single digits. - Stellantis NV stuck to its guidance for the year as the struggling carmaker fights to reduce costs, improve quality and roll out new models to counter intensifying competition particularly in Europe. - GSK Plc’s third-quarter profit report showed slumping vaccine sales, causing the biggest share plunge since April. See omnystudio.com/listener for privacy information.

## Transcript

[0:02] Speaker 1: Bloomberg Audio Studios.
[0:04] Speaker 2: Podcasts.
[0:05] Speaker 3: Radio. News.
[0:08] Speaker 1: The Stock Movers Report. Your roundup of companies making moves
[0:12] Speaker 1: in the stock market. Harnessing the power of Bloomberg data.
[0:16] Speaker 2: Let's take a look at some of the stocks on
[0:18] Speaker 2: the move today in Europe. I'm Tiwa Adebayo with Caroline Hepka.
[0:21] Speaker 2: And we're joined by Bloomberg reporter Josh Quint-Warner. So, Josh,
[0:25] Speaker 2: we're looking at European bank earnings. We've heard from a
[0:27] Speaker 2: slew of names, the likes of BNP Paribas, UBS. But
[0:31] Speaker 2: is Standard Chartered keeping up with its peers?
[0:34] Speaker 3: It certainly appears to be coming out on top this morning.
[0:37] Speaker 3: It's the best performer in the sector. It's up about 3.5%
[0:40] Speaker 3: at the moment, and that's following the strong gains that
[0:43] Speaker 3: we saw booked in Hong Kong overnight. You know, profit
[0:47] Speaker 3: rose by about 29% in the latest quarter. That topped
[0:50] Speaker 3: estimates and was driven by record net inflows into its
[0:53] Speaker 3: wealth unit and some robust trading activity. The wealth unit,
[0:57] Speaker 3: for example, lured a record $ 20 billion in net new money,
[1:00] Speaker 3: and flow trading income was also 21% higher. You know,
[1:04] Speaker 3: that strong performance has prompted it to lift its outlook
[1:06] Speaker 3: for the year. Operating income will grow more than previously
[1:10] Speaker 3: expected and return on tangible equity will reach about 14%
[1:13] Speaker 3: up from its prior goal of more than 12%. As
[1:16] Speaker 3: a result, we're seeing shares having their best day in
[1:18] Speaker 3: three months. That's extending a rebound following a period of
[1:22] Speaker 3: pressure since the stock hit all-time highs about a month ago.
[1:26] Speaker 3: Just flicking at some of the other bank earnings this morning,
[1:29] Speaker 3: Deutsche Bank is also performing well, up about 3%. after
[1:32] Speaker 3: beating US peers on fixed income trading revenue, while Santander
[1:37] Speaker 3: and UBS are the ones that are down about 2%
[1:39] Speaker 3: to 3% after failing to impress.
[1:42] Speaker 2: Okay.
[1:43] Speaker 1: So, those are the banks. What about the carmaker, Solantis?
[1:47] Speaker 1: What do we know about the turnaround? Yeah.
[1:49] Speaker 3: So, the Italian carmaker reported profits ahead of expectations this
[1:53] Speaker 3: morning and confirmed its guidance for the year. That's providing
[1:57] Speaker 3: a bounce after Stellantis shares hit an all-time low last week.
[2:01] Speaker 3: The intact outlook is being welcomed. We've seen guidance cuts
[2:04] Speaker 3: from several carmakers, especially in Germany. We saw Mercedes-Benz do
[2:08] Speaker 3: that just this week. In terms of negatives for Stellantis,
[2:12] Speaker 3: it booked losses in Europe as it struggles to compete
[2:14] Speaker 3: with Chinese brands. And industrial free cash flow was still
[2:18] Speaker 3: pretty much in the negative territory. But it is still
[2:21] Speaker 3: planning with its turnaround plan to deliver a positive free
[2:23] Speaker 3: cash flow next year. And also, earnings turned positive in
[2:27] Speaker 3: North America after introducing new models. So, some green shoots.
[2:31] Speaker 3: But today, it's more a relief bounce than anything. Shares
[2:34] Speaker 3: are still down 60% since the start of this year.
[2:37] Speaker 3: And that makes it the worst performer in the automotive
[2:39] Speaker 3: space in Europe.
[2:41] Speaker 1: Interesting.
[2:41] Speaker 2: So, that's the latest on the automotive space. But lastly,
[2:44] Speaker 2: we want to talk about pharmaceuticals. GSK slumping this morning.
[2:49] Speaker 2: What is all of that about?
[2:51] Speaker 3: Yeah, quite a hefty move. Down about 4%. That's its
[2:54] Speaker 3: worst day in about six months. What's weighing on the
[2:58] Speaker 3: stock is a slump in vaccine sales and also an
[3:01] Speaker 3: adjustment to guidance. So, profit rose 3% in the last quarter,
[3:06] Speaker 3: but that was driven more by legacy products like its
[3:08] Speaker 3: asthma drugs. But sales of vaccines like its blockbuster Shingle shot, Shingrix,
[3:14] Speaker 3: were down. Bloomberg Intelligence's John Murphy said the weak vaccine's
[3:18] Speaker 3: performance will raise questions over the growth outlook for its
[3:21] Speaker 3: drugs going forward. He suggested one of its drugs, Orexv,
[3:25] Speaker 3: might be facing more intense competition and that sales might
[3:29] Speaker 3: have even peaked for Shingrix. And the reason that's a
[3:31] Speaker 3: concern is because vaccines account for about 28% of sales
[3:35] Speaker 3: this year and is expected to drive about a third
[3:37] Speaker 3: of sales growth over the coming years. You know, GSK
[3:41] Speaker 3: also said it now expects to hit the lower half
[3:43] Speaker 3: of its guided profit growth this year. And so, that
[3:48] Speaker 3: is reversing some of the gains booked leading into the print.
[3:53] Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
[3:57] Speaker 1: us throughout the day for the latest roundup of companies
[3:59] Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
[4:04] Speaker 1: listen to Bloomberg Radio live. Catch us on YouTube, Bloomberg.com,
[4:08] Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
[4:11] Speaker 1: Business app.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.